QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

STOK

QT43Stoke Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
31.00
+0.74+2.45%
OverviewShort InterestFilings
STOKQT43Stoke Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
31.00+2.45%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.83
Insider Own22.24%
Shs Outstand62.28M
Perf Week5.59%
Market Cap1.88BForward P/E-EPS next Y-3.12Insider Trans0.34%Shs Float-Perf Month3.47%
Enterprise Value1.73BPEG-EPS next Q-0.73Inst Own-Short Float-Perf Quarter-6.60%
Income-167733216.00P/S58.75EPS this Y-13.84%Inst Trans-Short Ratio-Perf Half Y-7.77%
Sales32.08MP/B4.83EPS next Y3.24%ROA-38.30%Short Interest-Perf YTD-2.33%
Book/sh6.34P/C-EPS next 5Y-ROE-48.84%52W High40.22 -22.92%Perf Year165.87%
Cash/sh5.52P/FCF-EPS past 3/5Y-ROIC-45.41%52W Low11.17 177.53%Perf 3Y-
Dividend Est.-EV/EBITDA-10.56Sales past 3/5Y148.43% -Gross Margin90.36%Volatility3.47% 3.18%Perf 5Y-
Dividend TTM-EV/Sales54.00EPS Y/Y TTM-70.30%Oper. Margin-577.46%ATR (14)1.53Perf 10Y-
Dividend Ex-Date-Quick Ratio8.99Sales Y/Y TTM-13.51%Profit Margin-529.20%RSI (14)52.85Recom2.25
Dividend Gr. 3/5Y-Current Ratio8.99EPS Q/Q-141.58%SMA203.47%Beta0.79Target Price41.40
Payout0.00%Debt/Eq0.01Sales Q/Q-96.23%SMA50-3.34%Rel Volume3.45Prev Close30.26
Employees128LT Debt/Eq0.00EarningsAug 11SMA2000.85%Avg Volume564.58KPrice31.00
IPO DateJun 19, 2019Option/ShortYes / YesEPS/Sales Surpr.1.25% 0.00%Net Debt/EBITDA0.93Volume1,946,300Change2.45%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-23-26InitiatedWolfe ResearchOutperform$40
Feb-05-26InitiatedGuggenheimBuy$60
Jan-12-26ReiteratedWedbushOutperform$36
Jan-05-26ReiteratedLoop Capital Markets$35
Jan-05-26ReiteratedCanaccord GenuityBuy$28 → $36
Dec-16-25ReiteratedH.C. WainwrightBuy$35 → $50
Dec-15-25ReiteratedUBSNeutral$35 → $50
Nov-05-25ReiteratedCanaccord GenuityBuy$20 → $28
Oct-10-25ReiteratedNeedhamBuy$22 → $35
Aug-18-25ReiteratedBTIGNeutral$29 → $28
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3218437
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A300
Gross Profit2918437
Selling, General and Administrative Excl. Other706749
Research and Development14413889
Other Operating Expense100
Operating Income-184-21-101
Interest Expense
300
Unusual Expense
———
Non-Operating Income (Expense)-18-14-12
Net Income Before Taxes-171-7-89
Income Taxes
-100
Consolidated Net Income-169-7-89
Net Income From Continuing Operations-169-7-89
Net Income-169-7-89
EPS (Recurring)-2.83-0.12-1.65
EPS (Basic, Before Extraordinaries)-2.83-0.12-1.65
EPS (Diluted)-2.83-0.12-1.65
EBITDA-165-5-87
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio61.0310.18—
Gross Margin90.63100.00100.00
Operating Margin-575.00-11.41-272.97
Net Margin-528.13-3.80-240.54
Shares Outstanding635954
Market Capitalization1,9531,873—
Operating Lease Expense
———
Insider Trading Volume
$35.02$30.97$26.92$22.88$18.83● Close Price0.00M7.67M15.34M23.01M30.68MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Ticho BarryCHIEF MEDICAL OFFICERJun 01 '26Sale30.581,79554,89134,826Jun 03 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMay 01 '26Sale32.792,24373,54836,621May 05 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERApr 01 '26Sale32.661,83860,02938,864Apr 03 12:00 AM
Allan JonathanGENERAL COUNSEL & CORP SECMar 20 '26Sale33.699,293313,03819,543Mar 24 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMar 19 '26Sale29.991,46143,81540,702Mar 19 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMar 19 '26Option Exercise2.192,7305,97883,035Mar 19 12:00 AM
Allan JonathanGENERAL COUNSEL & CORP SECMar 18 '26Sale31.344,628145,06228,836Mar 19 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMar 18 '26Sale31.346,686209,56940,798Mar 19 12:00 AM
Leggett ThomasChief Financial OfficerMar 18 '26Sale31.342,38274,66310,172Mar 19 12:00 AM
Hoitt JasonChief Patient OfficerMar 18 '26Sale31.341,93160,52710,276Mar 19 12:00 AM
Allan JonathanGENERAL COUNSEL & CORP SECMar 17 '26Sale33.014,267140,83833,464Mar 19 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMar 17 '26Sale33.016,164203,45147,484Mar 19 12:00 AM
Leggett ThomasChief Financial OfficerMar 17 '26Sale33.012,19672,48212,554Mar 19 12:00 AM
Hoitt JasonChief Patient OfficerMar 17 '26Sale33.011,78158,78512,207Mar 19 12:00 AM
Ticho BarryCHIEF MEDICAL OFFICERMar 15 '26Option Exercise0.0067,700053,648Mar 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR